{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:59:48Z","timestamp":1791413988604,"version":"4.3.3"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Spinal anesthesia with intrathecal morphine is often the preferred anesthetic modality for elective cesarean delivery. Side effects and drug shortages, however, prompted researchers to look into intrathecal hydromorphone as an alternative. These studies established the effective analgesic dose for 90% of patients (ED90) for both opioids for postcesarean analgesia, yet failed to demonstrate the superiority of morphine over hydromorphone. Nonetheless, the noninferiority of hydromorphone has yet to be determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>In this noninferiority randomized blinded clinical trial, 126 patients undergoing elective cesarean delivery under spinal anesthesia received either morphine 150 \u00b5g or hydromorphone 75 \u00b5g (ED90). The primary outcome was the between-group difference of the mean Numeric Rating Scale (NRS) pain score (0\u201310) for the first 24 hours after cesarean delivery, with a preestablished threshold for noninferiority of 1. This 24-hour NRS pain score was defined as a single number obtained at the 24 hours postcesarean delivery interview, based on participant\u2019s recall of their overall pain experience during this period. Secondary outcomes included differences in NRS pain scores every 6 hours, cumulative 24 hour opioid consumption, time-to-first opioid request, quality of recovery as measured by the Obstetric Quality of Recovery Score-11 (ObsQoR-11), frequency of interventions for side effects, and Apgar scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The mean (standard deviation [SD]) of the 24-hour NRS pain score was 4.0 (1.7) for morphine and 3.6 (1.5) for hydromorphone (between-group difference \u20130.46 (95% confidence interval [CI], \u20131.0 to 0.1). Given that the upper limit of the 95% CI did not exceed 1, noninferiority of hydromorphone was established. No statistically significant differences were found in mean (SD) 24 hour oral morphine consumption (morphine: 4.2 mg (6.5) vs hydromorphone: 4.1 (8.0) mg;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .98), median [interquartile range {IQR}] ObsQoR-11 score (morphine: score 87 [75\u201397.5] vs hydromorphone: score 90 [80\u201396.5];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .51), median [IQR] time to first opioid request (morphine: 10.2 [3.2\u201315.5] h versus hydromorphone: 6.2 [3.1\u201312.4] h;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .35), or proportion of patients requiring interventions for opioid-related pruritus (morphine: 0.316 (variance 0.216) vs hydromorphone: 0.321 (variance 0.218) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .96) and opioid-related nausea and vomiting (morphine: 0.333 (variance 0.222) vs hydromorphone: 0.393 (variance 0.238) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .51).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Intrathecally, hydromorphone is noninferior to morphine for analgesia after elective cesarean delivery when using the previously established ED90 for both opioids (morphine: 150 \u00b5g versus hydromorphone: 75 \u00b5g); hydromorphone provides effective analgesia and may be a suitable alternative to morphine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000007580","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T13:00:29Z","timestamp":1749560429000},"page":"19-27","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Intrathecal Hydromorphone Versus Intrathecal Morphine for Postcesarean Delivery Analgesia: A Randomized Noninferiority Trial"],"prefix":"10.1213","volume":"142","author":[{"given":"Sonny","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, University of Western Ontario, London Health Sciences Centre, London, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bartolacci","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, University of Western Ontario, London Health Sciences Centre, London, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, University of Western Ontario, London Health Sciences Centre, London, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Dobrowlanski","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, University of Western Ontario, London Health Sciences Centre, London, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, University of Western Ontario, London Health Sciences Centre, London, Canada"},{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha Indu","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, University of Western Ontario, London Health Sciences Centre, London, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Sebbag","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, University of Western Ontario, London Health Sciences Centre, London, Canada"},{"name":"Department of Anesthesia, University of British Columbia, BC Women\u2019s Hospital, Vancouver, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"R1-20251215","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jogc.2019.09.009","article-title":"Examining cesarean section rates in Canada using the modified Robson classification.","volume":"42","author":"Gu","year":"2020","journal-title":"J Obstet Gynaecol Can"},{"key":"R2-20251215","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1213\/ANE.0000000000001677","article-title":"Choice of anesthesia for cesarean delivery: An analysis of the national anesthesia clinical outcomes registry.","volume":"124","author":"Juang","year":"2017","journal-title":"Anesth Analg"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1213\/ANE.0000000000004195","article-title":"Society for obstetric anesthesia and perinatology consensus statement: Monitoring recommendations for prevention and detection of respiratory depression associated with administration of neuraxial morphine for cesarean delivery analgesia.","volume":"129","author":"Bauchat","year":"2019","journal-title":"Anesth Analg"},{"key":"R4-20251215","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1213\/01.ANE.0000177101.99398.22","article-title":"The role of intrathecal drugs in the treatment of acute pain.","volume":"101","author":"Rathmell","year":"2005","journal-title":"Anesth Analg"},{"key":"R5-20251215","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2044.2008.05817.x","article-title":"Risks and side-effects of intrathecal morphine combined with spinal anaesthesia: A meta-analysis.","volume":"64","author":"Gehling","year":"2009","journal-title":"Anaesthesia"},{"key":"R6-20251215","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0885-3924(03)00144-1","article-title":"Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine\/opioid combinations.","volume":"26","author":"Ackerman","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"R7-20251215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1526-4637.2006.00083.x","article-title":"Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study.","volume":"7","author":"Du","year":"2006","journal-title":"Pain Med"},{"key":"R8-20251215","doi-asserted-by":"crossref","first-page":"283","DOI":"10.36076\/ppj.2011\/14\/E283","article-title":"Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain.","volume":"14","author":"Deer","year":"2011","journal-title":"Pain Physician"},{"key":"R9-20251215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.JAA.0000684128.83801.e6","article-title":"Intrathecal hydromorphone as an analgesia option for gynecology patients.","volume":"33","author":"Gajarawala","year":"2020","journal-title":"JAAPA"},{"key":"R10-20251215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijoa.2016.12.008","article-title":"Neuraxial opioids for post-cesarean delivery analgesia: Can hydromorphone replace morphine? A retrospective study.","volume":"30","author":"Marroquin","year":"2017","journal-title":"Int J Obstet Anesth"},{"key":"R11-20251215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpainsymman.2005.01.007","article-title":"Hydromorphone.","volume":"29","author":"Murray","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"R12-20251215","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/papr.12099","article-title":"Spinal opioid bioavailability in postoperative pain.","volume":"14","author":"Bujedo","year":"2014","journal-title":"Pain Pract"},{"key":"R13-20251215","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/ALN.0000000000003283","article-title":"Intrathecal morphine versus intrathecal hydromorphone for analgesia following aesarean delivery: A randomized clinical trial.","volume":"132","author":"Sharpe","year":"2020","journal-title":"Anesthesiology"},{"key":"R14-20251215","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1213\/ANE.0000000000001229","article-title":"Intrathecal hydromorphone and morphine for postcesarean delivery analgesia: Determination of the ED 90 using a sequential allocation biased-coin method.","volume":"123","author":"Sviggum","year":"2016","journal-title":"Anesth Analg"},{"key":"R15-20251215","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.pain.2012.12.017","article-title":"Single vs composite measures of pain intensity: Relative sensitivity for detecting treatment effects.","volume":"154","author":"Jensen","year":"2013","journal-title":"Pain"},{"key":"R16-20251215","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bja.2018.06.011","article-title":"Development and evaluation of an obstetric quality-of-recovery score (ObsQoR-11) after elective caesarean delivery.","volume":"122","author":"Ciechanowicz","year":"2019","journal-title":"Br J Anaesth"},{"key":"R17-20251215","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ajem.2005.07.009","article-title":"The minimum clinically significant difference in patient-assigned numeric scores for pain.","volume":"23","author":"Kendrick","year":"2005","journal-title":"Am J Emerg Med"},{"key":"R18-20251215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12916-016-0775-3","article-title":"Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain.","volume":"15","author":"Olsen","year":"2017","journal-title":"BMC Med"},{"key":"R19-20251215","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/bja\/aew466","article-title":"Measuring acute postoperative pain using the visual analog scale: The minimal clinically important difference and patient acceptable symptom state.","volume":"118","author":"Myles","year":"2017","journal-title":"Br J Anaesth"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:27:46Z","timestamp":1786112866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000007580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000007580","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]}}}